SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-122020
Filing Date
2023-11-29
Accepted
2023-11-29 16:01:15
Documents
2
Group Members
ARUN KUMAR PILLAI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2331705d1_sc13da.htm SC 13D/A 78956
2 EXHIBIT 1 tm2331705d1_ex1.htm EX-99.1 5004
  Complete submission text file 0001104659-23-122020.txt   85783
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89495 | Film No.: 231452101
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877
Business Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877 962 6 582 7999
Tenshi Healthcare Pte. Ltd. (Filed by) CIK: 0001716335 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A